Literature DB >> 33087564

Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data.

Elie Dolgin.   

Abstract

Mesh：

Year:  2020        PMID： 33087564      PMCID： PMC7668032          DOI： 10.1073/pnas.2020930117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  7 in total

Review 1.  Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic.

Authors:  Anton Pottegård; Xavier Kurz; Nicholas Moore; Christian F Christiansen; Olaf Klungel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2020-05-21       Impact factor: 2.890

2.  Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data.

Authors:  Katsiaryna Bykov; Mengdong He; Jessica M Franklin; Elizabeth M Garry; John D Seeger; Elisabetta Patorno
Journal:  Diabetes Obes Metab       Date:  2019-05-29       Impact factor: 6.577

3.  Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.

Authors:  Marc L Berger; Harold Sox; Richard J Willke; Diana L Brixner; Hans-Georg Eichler; Wim Goettsch; David Madigan; Amr Makady; Sebastian Schneeweiss; Rosanna Tarricone; Shirley V Wang; John Watkins; C Daniel Mullins
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-09       Impact factor: 2.890

4.  A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.

Authors:  David R Boulware; Matthew F Pullen; Ananta S Bangdiwala; Katelyn A Pastick; Sarah M Lofgren; Elizabeth C Okafor; Caleb P Skipper; Alanna A Nascene; Melanie R Nicol; Mahsa Abassi; Nicole W Engen; Matthew P Cheng; Derek LaBar; Sylvain A Lother; Lauren J MacKenzie; Glen Drobot; Nicole Marten; Ryan Zarychanski; Lauren E Kelly; Ilan S Schwartz; Emily G McDonald; Radha Rajasingham; Todd C Lee; Kathy H Hullsiek
Journal:  N Engl J Med       Date:  2020-06-03       Impact factor: 91.245

5.  Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.

Authors:  Mandeep R Mehra; Frank Ruschitzka; Amit N Patel
Journal:  Lancet       Date:  2020-06-05       Impact factor: 79.321

6.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

7.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283
  7 in total
  1 in total

1.  Linking digital surveillance and in-depth virology to study clinical patterns of viral respiratory infections in vulnerable patient populations.

Authors:  Patrick E Obermeier; Albert Heim; Barbara Biere; Elias Hage; Maren Alchikh; Tim Conrad; Brunhilde Schweiger; Barbara A Rath
Journal:  iScience       Date:  2022-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.